ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

Concepts Approved For $26.5Million In DCPC contracts, Including Heavy Smoker Program

February 1, 1985

Half Of Women Complete Full Hormone Therapy Regimen

July 30, 2010

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

ASCO Selects Three Cities For Quality Of Care Study.

June 2, 2000